Literature DB >> 3093579

The intracellular retention of newly synthesized platelet-activating factor.

J M Lynch, P M Henson.   

Abstract

The ether phospholipid platelet-activating factor (PAF) has been generally assumed to be released into the extracellular environment by the cells of origin, whereupon it effects its well-known mediator functions. However, during the generation of PAF by human neutrophils, it was noted that the majority of the measurable PAF remained associated with the cells. Accordingly, the intracellular and extracellular distribution of PAF was examined in neutrophils and several other cell types. No PAF was detected in association with unstimulated neutrophils. However, in stimulated neutrophils, PAF was produced and the majority of this material remained in association with the cells independent of the type of stimulus, dose of stimulus, or method of cell isolation used. This pattern of cell association of PAF was seen in all but one of the cell types tested. The retention of PAF by stimulated neutrophils was not due to spurious underestimates of the extracellular levels due to extracellular metabolism and inactivation of released PAF, nor to release followed by readsorption or binding of PAF to the cells. The retention of PAF also occurred in the presence of plasma and appears to be a common phenomenon. Thus, the majority of newly synthesized PAF appears to be retained within the cell and not released.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093579

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Radioimmunoassay for platelet-activating factor.

Authors:  K Karasawa; N Satoh; T Hongo; Y Nakagawa; M Setaka; S Nojima
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Determination of platelet-activating factor by a chemiluminescence method and its application to stimulated guinea pig neutrophils.

Authors:  Y Hasegawa; E Kunow; J Shindou; H Yuki
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds.

Authors:  C M Hogaboam; D Donigi-Gale; T S Shoupe; E Y Bissonnette; A D Befus; J L Wallace
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

4.  The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis.

Authors:  S Fernández-Gallardo; M A Gijón; C García; V Furio; F T Liu; M Sánchez Crespo
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

5.  Platelet-activating-factor-mediated pathogenesis in Lyme disease.

Authors:  E Isogai; K Kimura; N Fujii; T Nishikawa; N Ishii; D Postic; G Baranton; H Isogai
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

6.  Platelet-activating factor may participate in signal transduction processes in rabbit leukocytes.

Authors:  A G Stewart; T Harris
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

7.  Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase.

Authors:  C C Silliman; K L Clay; G W Thurman; C A Johnson; D R Ambruso
Journal:  J Lab Clin Med       Date:  1994-11

8.  Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers.

Authors:  T Imaizumi; K Satoh; H Yoshida; Y Kawamura; M Hiramoto; M Koyanagi; S Takamatsu; M Takamatsu
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

9.  Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.

Authors:  A G Stewart; T Harris; M De Nichilo; A F Lopez
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

10.  Studies on the role of platelet-activating factor in blood pressure regulation.

Authors:  K Sakaguchi; S Morimoto; F Masugi; S Saeki; T Ogihara; K Yamada; I Yamatsu
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.